Skip to content

Clinical trials

Completed Lysosomal Storage Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Status: Completed Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20062
20071
20083
20094
20103
20118
20122
20132
20145
20154
20161
20172
20183
20194
20204
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire7
Alexion Pharmaceuticals, Inc.6
Amicus Therapeutics4
BioMarin Pharmaceutical4
Ultragenyx Pharmaceutical Inc4
AO GENERIUM2
Duke University2
National Institute of Neurological Disorders and Stroke (NINDS)2
Orchard Therapeutics2
University of California, San Diego2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases56
Metabolic Diseases12
Mucopolysaccharidosis II11
Mucopolysaccharidoses9
Genetic Diseases, Inborn8
Metabolism, Inborn Errors7
Sudden Infant Death7
Wolman Disease6
Cholesterol Ester Storage Disease5
Gaucher Disease5

Trials

Showing 51 to 56 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.